0LUS.L
Welltower Inc.
LSEUSDEQUITY
DELAYED
Last price
238.22
▲ 1.32 (0.56%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
236.90
Day high
243.50
Day low
237.51
Volume
5
Market cap
—
P/E (TTM)
3.19
52W range
65.69 – 243.50
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 0LUS.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
439.65K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 26, 26 | MITRA SHANKH Chief Executive Officer |
STOCK | 3.85K | $0 | Direct |
| May 29, 26 | MITRA SHANKH Chief Executive Officer |
STOCK | 17 | $2.95K | Direct |
| May 27, 26 | MITRA SHANKH Chief Executive Officer |
STOCK | 162 | $0 | Direct |
| May 21, 26 | LOPEZ DENNIS G Director |
STOCK | 63 | $13.61K | Direct |
| May 1, 26 | BACON KENNETH J Director |
— | 2.63K | — | Direct |
| Feb 26, 26 | RIVERA SERGIO DAVID Director |
STOCK | 1.06K | $0 | Direct |
| Feb 26, 26 | DESALVO KAREN B Director |
STOCK | 1.06K | $0 | Direct |
| Feb 26, 26 | SPISSO JOHNESE M Director |
STOCK | 1.06K | $0 | Direct |
| Feb 26, 26 | LOPEZ DENNIS G Director |
STOCK | 1.79K | $0 | Direct |
| Feb 13, 26 | MCQUEEN MATTHEW GRANT Officer |
STOCK | 541 | $0 | Direct |
| Dec 31, 25 | LOPEZ DENNIS G Director |
STOCK | 57 | $0 | Direct |
| Dec 16, 25 | MCHUGH TIMOTHY President |
STOCK | 500 | $0 | Direct |
| Nov 28, 25 | MCHUGH TIMOTHY President |
STOCK | 53 | $11.04K | Direct |
| Nov 28, 25 | CHAUDHRI NIKHIL President |
STOCK | 31 | $6.46K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BACON KENNETH J |
Director | 14.31K | Conversion of Exercise of derivative security |
DESALVO KAREN B |
Director | 12.37K | Stock Award(Grant) |
FIEWEGER JOSHUA |
Officer | 21.39K | Stock Award(Grant) |
GUNDLACH ANDREW |
Director | — | Purchase |
LOPEZ DENNIS G |
Director | 18.52K | Stock Award(Grant) |
MCHUGH TIMOTHY |
President | 23.42K | Stock Gift |
MCQUEEN MATTHEW GRANT |
Officer | 26.88K | Stock Gift |
MITRA SHANKH |
Chief Executive Officer | 72.70K | Stock Gift |
RIVERA SERGIO DAVID |
Director | 26.61K | Stock Award(Grant) |
SPISSO JOHNESE M |
Director | 16.06K | Stock Award(Grant) |
Fundamentals
Market cap—
Enterprise value$191.98B
Revenue (TTM)$12.76B
Gross profit$5.05B
EBITDA$3.34B
Net income$1.55B
EPS (TTM)$0.75
Free cash flow$2.76B
Total cash$1.97B
Total debt$19.72B
Book value / share$64.56
Shares outstanding375.64M
Float719.76M
Short % of float—
Dividend yield—
Beta (5Y)0.76
Valuation & profitability ratios
Trailing P/E3.19
Forward P/E—
PEG ratio—
Price / sales—
Price / book3.69
EV / revenue15.04
EV / EBITDA57.47
Gross margin39.56%
Operating margin16.56%
Profit margin12.15%
Return on equity3.84%
Return on assets0.83%
Debt / equity41.38
Current ratio1.32
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $3.69B | +37.4% |
| Next quarter | — | — | $3.91B | +23.0% |
| Current year | — | — | $14.37B | +32.6% |
| Next year | — | — | $16.78B | +16.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.06%
Held by institutions101.41%
Institutions holding2.18K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
0.76
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 24 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Sep 23, 24 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Sep 16, 24 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Aug 28, 24 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Aug 21, 24 | Deutsche Bank | MAINTAINED | Buy | Buy |
| Aug 9, 24 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 7, 24 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Aug 5, 24 | Wedbush | MAINTAINED | Neutral | Neutral |
| Jul 16, 24 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jul 11, 24 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 2, 24 | Keybanc | MAINTAINED | Overweight | Overweight |
| May 30, 24 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Headlines
3 Market-Beating Stocks to Keep an Eye On
StockStory · 14m ago
Sun's Out, Fun's Out: Club Med opens 2027 sales bookings for bold escapes to new destinations and iconic getaways
PR Newswire · 15m ago
Prepayments, Realkredit Danmark A/S
GlobeNewswire · 16m ago
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Business Wire · 19m ago
The hidden productivity drain costing Australian businesses thousands of hours: Omniche Advisory says organisations are overlooking a major productivity opportunity by allowing highly skilled employees to spend too much time on repetitive tasks
PR Newswire · 21m ago
3 Market-Beating Stocks with Exciting Potential
StockStory · 22m ago
Quadient Digital Delivers Over 20% Q2 Bookings Growth, Driven by AI-Powered Automation and E-Invoicing
GlobeNewswire · 25m ago
New board members to transform Thames Water announced
GlobeNewswire · 25m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.